• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Determination of dobutamine levels in human plasma--methodological and clinical aspects].

作者信息

Knoll R, Brandl M

出版信息

Anasth Intensivther Notfallmed. 1986 Feb;21(1):34-7.

PMID:3963322
Abstract

We developed a simple method for the routine determination of dobutamine in human plasma. With a relatively small amount of equipment--such as HPLC pump, RP 18-column, sample valve, fluorescence detector and an integrator--dobutamine levels could be determined quickly after a simple extraction procedure on Bond-Elut-CN-columns. In the case of critically ill patients suffering from different kinds of shock we found a wide variation of plasma levels in arterial blood samples. Even with an exact application of dobutamine in relatively low doses of about 2.5 micrograms/kg BW/min to 5 micrograms/kg BW/min, levels reached from 26.8 to 181 micrograms/ml. In our opinion, one reason for these variations might be a differing volume of distribution caused by varying intravascular volumes in critically ill patients. A further possibility might be a different degree of sulfoconjugation of dobutamine. Therefore, the occasional occurrence of tachycardia under dobutamine therapy could be caused by relatively high plasma levels of free dobutamine.

摘要

相似文献

1
[Determination of dobutamine levels in human plasma--methodological and clinical aspects].
Anasth Intensivther Notfallmed. 1986 Feb;21(1):34-7.
2
Dobutamine infusions in stable, critically ill children: pharmacokinetics and hemodynamic actions.在病情稳定的重症儿童中静脉输注多巴酚丁胺:药代动力学和血流动力学作用
Crit Care Med. 1993 May;21(5):678-86. doi: 10.1097/00003246-199305000-00010.
3
Variability in dobutamine pharmacokinetics in unstable critically ill surgical patients.不稳定危重症外科患者多巴酚丁胺药代动力学的变异性
Crit Care Med. 1994 Dec;22(12):1926-32.
4
Cardiotonic agents: a simple HPLC procedure for the quantitation of dobutamine and a new congener in plasma.
Res Commun Chem Pathol Pharmacol. 1985 May;48(2):313-6.
5
Sex steroid hormones in circulatory shock, sepsis syndrome, and septic shock.循环性休克、脓毒症综合征及感染性休克中的性甾体激素。
Circ Shock. 1994 Aug;43(4):171-8.
6
Dobutamine effect on ankle-brachial pressure index in patients with peripheral arterial occlusive disease. New noninvasive test for evaluation of peripheral circulation?多巴酚丁胺对周围动脉闭塞性疾病患者踝肱压力指数的影响。一种用于评估外周循环的新型无创检测方法?
Int Angiol. 1998 Sep;17(3):201-7.
7
Dobutamine pharmacokinetics and pharmacodynamics in normal children and adolescents.多巴酚丁胺在正常儿童和青少年中的药代动力学与药效学
J Pharmacol Exp Ther. 1993 Jun;265(3):1232-8.
8
High-pressure liquid chromatographic determination of plasma dobutamine concentrations.
J Pharm Sci. 1978 Dec;67(12):1756-7. doi: 10.1002/jps.2600671233.
9
Sulfoconjugation and renal excretion contribute to the interpatient variation of exogenous catecholamine clearance in critically ill children.硫酸结合作用和肾脏排泄导致了危重症儿童中外源性儿茶酚胺清除率的个体间差异。
Crit Care Med. 1997 Jul;25(7):1247-51. doi: 10.1097/00003246-199707000-00030.
10
[The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].[多巴酚丁胺 - 多巴胺联合用药与氨力农治疗伴有明显水肿体征并并发功能性肾衰竭的充血性心力衰竭。两种不同的变力性刺激和利尿增强模型的比较]
Minerva Cardioangiol. 1998 May;46(5):163-74.

引用本文的文献

1
A sensitive method for the simultaneous UHPLC-MS/MS analysis of milrinone and dobutamine in blood plasma using NHF as the eluent additive and ascorbic acid as a stabilizer.一种以NHF作为洗脱添加剂、抗坏血酸作为稳定剂,用于同时血浆中米力农和多巴酚丁胺的超高效液相色谱-串联质谱分析的灵敏方法。
Clin Mass Spectrom. 2019 Mar 18;12:23-29. doi: 10.1016/j.clinms.2019.03.003. eCollection 2019 Apr.